0001683168-24-000223.txt : 20240111 0001683168-24-000223.hdr.sgml : 20240111 20240111165204 ACCESSION NUMBER: 0001683168-24-000223 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240109 FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Matsuda Kazuko CENTRAL INDEX KEY: 0001531140 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33185 FILM NUMBER: 24529785 MAIL ADDRESS: STREET 1: C/O MEDICINOVA, INC. STREET 2: 4275 EXECUTIVE SQUARE, SUITE 650 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICINOVA INC CENTRAL INDEX KEY: 0001226616 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 330927979 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 858-373-1500 MAIL ADDRESS: STREET 1: 4275 EXECUTIVE SQUARE STREET 2: SUITE 300 CITY: LA JOLLA STATE: CA ZIP: 92037 4 1 ownership.xml X0508 4 2024-01-09 0 0001226616 MEDICINOVA INC MNOV 0001531140 Matsuda Kazuko C/O MEDICINOVA, INC. 4275 EXECUTIVE SQUARE, SUITE 300 LA JOLLA CA 92037 1 1 0 0 Chief Medical Officer 0 Employee Stock Option (Right to Buy) 2.40 2024-01-09 4 A 0 157500 0 A 2024-01-09 2033-01-31 Common Stock 157500 157500 D On February 1, 2023, the reporting person was granted an option to purchase 225,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 157,500 shares. /s/ Yuichi Iwaki, attorney-in-fact 2024-01-11